Evidence map›Paper›PMID 30700556›Full record

ArticleThe Journal of biological chemistry2019

Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2.

Naoka Yamamoto, Manabu Kashiwagi, Manami Ishihara, Takaaki Kojima, Andrés D Maturana, Shun'ichi Kuroda, Tomoaki Niimi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Role of NEL‑like molecule‑1 in osteogenesis/chondrogenesis (Review).International journal of molecular medicine · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Structure and evolution of neuronal wiring receptors and ligands.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Role of Slit/Robo Signaling pathway in Bone Metabolism.International journal of biological sciences · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Naoka YamamotoFrom the Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan and.
Manabu KashiwagiFrom the Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan and.
Manami IshiharaFrom the Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan and.
Takaaki KojimaFrom the Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan and.
Andrés D MaturanaFrom the Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan and.
Shun'ichi Kurodathe Institute of Scientific and Industrial Research, Osaka University, Osaka 567-0047, Japan.
Tomoaki NiimiFrom the Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan and tniimi@agr.nagoya-u.ac.jp.
Nagoya University · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The signaling pathways that are mediated by Slit ligands and their Roundabout (Robo) family of receptors play multifunctional roles in the development of the nervous system and other organs. A recent study identified neural epidermal growth factor-like (NEL)-like 2 (NELL2) as a novel ligand for Robo3. In this study, we carried out a comprehensive analysis of the interaction between NELL1 and the Robo family of receptors and demonstrated that Robo2 contains a cryptic binding site for both NELL1 and NELL2. NELL1/2 binds to the first fibronectin type III (FNIII) domain of Robo2 but not to intact Robo2. Mutation analysis revealed that several amino acids within the first FNIII domain are critical for NELL1 binding to Robo2 but not to Robo1. The Robo2 deletion mutants without the fourth immunoglobulin domain and single amino acid substitution mutants that can influence the architecture of the ectodomain facilitated binding to NELL1/2. Acidic conditions increased the binding affinity of Robo2 for NELL1. These results suggest that Robo2 functions as a receptor for NELL1/2, particularly under circumstances where Robo2 undergoes proteolytic digestion. If this is not the case, conformational changes of the ectodomain of Robo2 may unmask the binding site for NELL1/2.

Indexed as

AcidsAmino Acid SequenceAmino Acid SubstitutionBinding SitesCalcium-Binding ProteinsHumansHydrogen-Ion ConcentrationMutationNerve Tissue ProteinsProteolysisReceptors, ImmunologicRoundabout ProteinsAcidsCalcium-Binding ProteinsNELL1 protein, humanNELL2 protein, humanNerve Tissue ProteinsReceptors, ImmunologicROBO2 protein, humanRoundabout Proteinscell surface receptorprotein conformationprotein domainprotein-protein interactionstructural model

Identifiers

PMID30700556
PMCPMC6433047
OpenAlexW2911818284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.